Gastroenterology and Hepatology Clinical Research Update: 2005–2006
This article is based on a presentation at the Plenary Session of the Annual Meeting of the American Gastroenterological Association during Digestive Disease Week, Los Angeles, CA, May 2006.
published online 04 September 2006.
This review highlights areas of clinical research in gastroenterology and hepatology that were published predominantly in the journal Clinical Gastroenterology and Hepatology during the last year and were summarized during the American Gastroenterological Association Presidential Plenary Session in May 2006. The topics included eosinophilic esophagitis in children, detecting high-grade dysplasia or carcinoma in Barrett’s esophagus, advances in management of celiac disease with elemental diet or gluten predigestion, the safety of NSAIDs in inflammatory bowel disease, the role of steroids in development of abscesses, prognosis of colorectal cancer associated with inflammatory bowel disease, screening for familial colorectal cancer in apparently sporadic disease, a new syndrome of familial colorectal cancer, new drugs in the treatment of chronic constipation and obesity, hepatoma risk factors and underserved racial/ethnic groups, and the application of new imaging and biology in diagnosis of gastroenterological disorders.
Address requests for reprints to: Michael Camilleri, MD, Mayo Clinic College of Medicine, Clinical Enteric Neuroscience Translational and Epidemiological Research (C.E.N.T.E.R.) Program, Charlton 8-110, 200 First St SW, Rochester, Minnesota 55905.
1 Dr Camilleri has received research grants from Sucampo to study effects of lubiprostone, and he has consulted for Sucampo-Takeda and Sanofi-Aventis.
ABSTRACT